Please Wait.....
Report
NA Non-Hodgkin Lymphoma Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-04-01 I 293 Pages I Data Bridge Market Research
The North America Non-Hodgkin lymphoma diagnostics market is projected to register a substantial CAGR of 9.1% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
North America Non-Hodgkin Lymphoma Diagnostics Market, By Test Type (Imaging, Biopsy, Immunohistochemistry, Biomarker Test, Genetic Test, Cytogenetics, Lumbar Puncture (Spinal Tap), Blood Test and Cytochemistry), Cancer Stage (Stage IV, Stage III, Stage II, Stage I, and Stage 0), Tumor Type (Aggressive Lymphomas and Indolent Lymphomas), Product (Instrument Based Products, Platform Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic Hybridization, Immunohistochemical and Others), Application (Screening, Diagnostic and Predictive, Prognostic, and Research), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the North America Non-Hodgkin lymphoma diagnostics market are:
- Increased growth in the prevalence of Non-Hodgkin Lymphoma
- Advancement in artificial intelligence in the diagnosis of Non-Hodgkin Lymphoma
Market Players:
Some of the major players operating in the North America Non-Hodgkin lymphoma diagnostics market are:
- CANON MEDICAL SYSTEMS CORPORATION
- Koninklijke Philips N.V.
- Siemens Healthcare GmbH
- Danaher.
- Bio-Rad Laboratories, Inc.
- General Electric Company
- Sysmex Corporation
- Grail
- F. Hoffmann-La Roche
- Neusoft Corporation
- Agilent Technologies, Inc.
- NeoGenomics Laboratories
- Hologic, Inc
- Integrated DNA Technologies, Inc.
- CENTOGENE N.V.
- Merit Medical Systems
- Invitae Corporation
- PerkinElmer Inc.
- QIAGEN
- GeneDx, LLC
TABLE OF CONTENTS
1 INTRODUCTION 83
1.1 OBJECTIVES OF THE STUDY 83
1.2 MARKET DEFINITION 83
1.3 OVERVIEW OF THE NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTICS MARKET 83
1.4 LIMITATIONS 85
1.5 MARKETS COVERED 86
2 MARKET SEGMENTATION 89
2.1 MARKETS COVERED 89
2.2 GEOGRAPHICAL SCOPE 90
2.3 YEARS CONSIDERED FOR THE STUDY 91
2.4 CURRENCY AND PRICING 91
2.5 DBMR TRIPOD DATA VALIDATION MODEL 92
2.6 MULTIVARIATE MODELLING 95
2.7 PRODUCT TYPE LIFELINE CURVE 95
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 96
2.9 DBMR MARKET POSITION GRID 97
2.10 MARKET APPLICATION COVERAGE GRID 98
2.11 VENDOR SHARE ANALYSIS 99
2.12 SECONDARY SOURCES 100
2.13 ASSUMPTIONS 100
3 EXECUTIVE SUMMARY 101
4 PREMIUM INSIGHTS 104
4.1 PESTEL ANALYSIS 105
4.2 PORTER'S 5 FORCES 106
5 INDUSTRY INSIGHTS 107
6 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTICS MARKET, REGULATIONS 108
7 MARKET OVERVIEW 110
7.1 DRIVERS 112
7.1.1 INCREASED GROWTH IN PREVALENCE OF NON-HODGKIN LYMPHOMA 112
7.1.2 INCREASE IN AWARENESS REGARDING NON-HODGKIN LYMPHOMA 112
7.1.3 ADVANCEMENT IN ARTIFICIAL INTELLIGENCE IN DIAGNOSIS OF NON-HODGKIN LYMPHOMA 112
7.1.4 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UP 113
7.2 RESTRAINTS 113
7.2.1 LACK OF AVAILABILITY OF TRAINED AND SKILLED MEDICAL PROFESSIONALS 113
7.2.2 STRINGENT REGULATIONS AND GUIDELINES FOR DIFFERENT TREATMENTS AND DIAGNOSIS 114
7.3 OPPORTUNITIES 115
7.3.1 TECHNICAL ADVANCEMENTS IN CANCER DIAGNOSIS 115
7.3.2 INCREASING HEALTHCARE EXPENDITURE IN CANCER R&D 115
7.3.3 GROWING INITIATIVES BY GOVERNMENT AND KEY PLAYERS 115
7.4 CHALLENGES 116
7.4.1 LACK OF EARLY DIAGNOSTIC AWARENESS AMONG PEOPLE 116
7.4.2 HIGH DIAGNOSTIC COST AND FEAR OF TREATMENT 116
7.4.3 COMMON MISDIAGNOSIS OF NON-HODGKIN LYMPHOMA (NHL) 117
8 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY TEST TYPE 118
8.1 OVERVIEW 119
8.2 IMAGING 122
8.2.1 COMPUTED TOMOGRAPHY (CT) 123
8.2.2 CHEST X-RAY 123
8.2.3 MAGNETIC RESONANCE IMAGING (MRI) 123
8.2.4 ULTRASOUND 123
8.2.5 POSITRON EMISSION TOMOGRAPHY (PET) 123
8.3 BIOPSY 123
8.3.1 EXCISIONAL OR INCISIONAL BIOPSY 124
8.3.2 CORE NEEDLE BIOPSY 124
8.4 IMMUNOHISTOCHEMISTRY 124
8.5 BIOMARKER TEST 125
8.5.1 BETA 2-M 126
8.5.2 LDH 126
8.5.3 CA-125 126
8.5.4 TP53 126
8.5.5 NPM1 127
8.5.6 OTHERS 127
8.6 GENETIC TEST 127
8.7 CYTOGENETICS 127
8.8 LUMBAR PUNCTURE (SPINAL TAP) 128
8.9 BLOOD TEST 129
8.10 CYTOCHEMISTRY 129
8.11 OTHERS 130
9 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY TUMOR TYPE 131
9.1 OVERVIEW 132
9.2 AGGRESSIVE LYMPHOMAS 134
9.2.1 DIFFUSE LARGE B CELL LYMPHOMA 135
9.2.1.1 INSTRUMENT BASED PRODUCTS 136
9.2.1.2 PLATFORM BASED PRODUCTS 136
9.2.1.3 KITS AND REAGENTS 136
9.2.1.4 OTHER CONSUMABLES 136
9.2.2 ANAPLASTIC LARGE-CELL LYMPHOMA 136
9.2.2.1 INSTRUMENT BASED PRODUCTS 137
9.2.2.2 PLATFORM BASED PRODUCTS 137
9.2.2.3 KITS AND REAGENTS 137
9.2.2.4 OTHER CONSUMABLES 137
9.2.3 MANTLE CELL LYMPHOMA 137
9.2.3.1 INSTRUMENT BASED PRODUCTS 138
9.2.3.2 PLATFORM BASED PRODUCTS 138
9.2.3.3 KITS AND REAGENTS 138
9.2.3.4 OTHER CONSUMABLES 138
9.2.4 PERIPHERAL T-CELL LYMPHOMA 138
9.2.4.1 INSTRUMENT BASED PRODUCTS 139
9.2.4.2 PLATFORM BASED PRODUCTS 139
9.2.4.3 KITS AND REAGENTS 139
9.2.4.4 OTHER CONSUMABLES 139
9.2.5 LYMPHOBLASTIC LYMPHOMA 139
9.2.5.1 INSTRUMENT BASED PRODUCTS 140
9.2.5.2 PLATFORM BASED PRODUCTS 140
9.2.5.3 KITS AND REAGENTS 140
9.2.5.4 OTHER CONSUMABLES 140
9.2.6 BURKITT LYMPHOMA 140
9.2.6.1 INSTRUMENT BASED PRODUCTS 141
9.2.6.2 PLATFORM BASED PRODUCTS 141
9.2.6.3 KITS AND REAGENTS 141
9.2.6.4 OTHER CONSUMABLES 141
9.3 INDOLENT LYMPHOMAS 141
9.3.1 FOLLICULAR LYMPHOMA 142
9.3.1.1 INSTRUMENT BASED PRODUCTS 143
9.3.1.2 PLATFORM BASED PRODUCTS 143
9.3.1.3 KITS AND REAGENTS 143
9.3.1.4 OTHER CONSUMABLES 143
9.3.2 CUTANEOUS T-CELL LYMPHOMA 143
9.3.2.1 INSTRUMENT BASED PRODUCTS 144
9.3.2.2 PLATFORM BASED PRODUCTS 144
9.3.2.3 KITS AND REAGENTS 144
9.3.2.4 OTHER CONSUMABLES 144
9.3.3 MARGINAL ZONE B CELL LYMPHOMA 144
9.3.3.1 INSTRUMENT BASED PRODUCTS 145
9.3.3.2 PLATFORM BASED PRODUCTS 145
9.3.3.3 KITS AND REAGENTS 145
9.3.3.4 OTHER CONSUMABLES 145
9.3.4 LYMPHOPLASMACYTIC LYMPHOMA 145
9.3.4.1 INSTRUMENT BASED PRODUCTS 146
9.3.4.2 PLATFORM BASED PRODUCTS 146
9.3.4.3 KITS AND REAGENTS 146
9.3.4.4 OTHER CONSUMABLES 146
9.3.5 SMALL-CELL LYMPHOCYTIC LYMPHOMA 146
9.3.5.1 INSTRUMENT BASED PRODUCTS 147
9.3.5.2 PLATFORM BASED PRODUCTS 147
9.3.5.3 KITS AND REAGENTS 147
9.3.5.4 OTHER CONSUMABLES 147
10 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY APPLICATION 148
10.1 OVERVIEW 149
10.2 SCREENING 151
10.2.1 INSTRUMENT BASED PRODUCTS 152
10.2.2 PLATFORM BASED PRODUCTS 152
10.2.3 KITS AND REAGENTS 153
10.2.4 OTHER CONSUMABLES 153
10.3 DIAGNOSTIC AND PREDICTIVE 153
10.3.1 INSTRUMENT BASED PRODUCTS 154
10.3.2 PLATFORM BASED PRODUCTS 154
10.3.3 KITS AND REAGENTS 154
10.3.4 OTHER CONSUMABLES 154
10.4 PROGNOSTIC 154
10.4.1 INSTRUMENT BASED PRODUCTS 155
10.4.2 PLATFORM BASED PRODUCTS 155
10.4.3 KITS AND REAGENTS 155
10.4.4 OTHER CONSUMABLES 156
10.5 RESEARCH 156
10.5.1 INSTRUMENT BASED PRODUCTS 157
10.5.2 PLATFORM BASED PRODUCTS 157
10.5.3 KITS AND REAGENTS 157
10.5.4 OTHER CONSUMABLES 157
11 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTICS MARKET, BY CANCER STAGE 158
11.1 OVERVIEW 159
11.2 STAGE IV 161
11.3 STAGE I 162
11.4 STAGE III 163
11.5 STAGE II 164
11.6 STAGE 0 165
12 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY TECHNOLOGY 166
12.1 OVERVIEW 167
12.2 FLUORESCENT IN SITU HYBRIDIZATION 169
12.3 NEXT GENERATION SEQUENCING 170
12.4 FLUORIMMUNOASSAY 171
12.5 COMPARATIVE GENOMIC HYBRIDIZATION 172
12.6 IMMUNOHISTOLOCHEMICAL 172
12.7 OTHER 173
13 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY PRODUCT 174
13.1 OVERVIEW 175
13.2 INSTRUMENT BASED PRODUCTS 177
13.2.1 IMAGING 178
13.2.2 BIOPSY 178
13.3 PLATFORM BASED PRODUCTS 179
13.3.1 NEXT-GENERATION SEQUENCING 180
13.3.2 MICROARRAYS 180
13.3.3 PCR 180
13.3.4 OTHERS 180
13.4 KITS AND REAGENTS 180
13.4.1 NON-HODGKIN LYMPHOMA PANELS 181
13.4.2 IMMUNOHISTOCHEMISTRY STAINS 181
13.4.3 OTHERS 181
13.5 OTHER CONSUMABLES 182
14 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY END USER 183
14.1 OVERVIEW 184
14.2 HOSPITALS 186
14.3 DIAGNOSTIC CENTERS 187
14.4 CANCER RESEARCH CENTERS 188
14.5 ACADEMIC INSTITUTES 189
14.6 AMBULATORY SURGICAL CENTERS 189
14.7 OTHERS 190
15 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL 191
15.1 OVERVIEW 192
15.2 DIRECT TENDER 194
15.3 RETAIL SALES 195
15.4 OTHERS 196
16 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTICS MARKET, BY REGION 197
16.1 NORTH AMERICA 198
16.1.1 U.S. 216
16.1.2 CANADA 228
16.1.3 MEXICO 240
17 NORTH AMERICA NON-HODGKIN LYMPHOMA DIAGNOSTICS MARKET: COMPANY LANDSCAPE 252
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 252
18 SWOT ANALYSIS 253
19 NORTH AMERICA NON-HODKIN LYMPHOMA DIAGNOSTICS MARKET 254
19.1 CANON MEDICAL SYSTEMS CORPORATION 254
19.1.1 COMPANY SNAPSHOT 254
19.1.2 REVENUE ANALYSIS 254
19.1.3 COMPANY SHARE ANALYSIS 255
19.1.4 PRODUCT PORTFOLIO 255
19.1.5 RECENT DEVELOPMENT 255
19.2 KONINKLIJKE PHILIPS N.V. 256
19.2.1 COMPANY SNAPSHOT 256
19.2.2 REVENUE ANALYSIS 256
19.2.3 COMPANY SHARE ANALYSIS 257
19.2.4 PRODUCT PORTFOLIO 257
19.2.5 RECENT DEVELOPMENTS 257
19.3 SIEMENS HEALTHCARE GMBH 258
19.3.1 COMPANY SNAPSHOT 258
19.3.2 REVENUE ANALYSIS 258
19.3.3 COMPANY SHARE ANALYSIS 259
19.3.4 PRODUCT PORTFOLIO 259
19.3.5 RECENT DEVELOPMENT 260
19.4 DANAHER. 261
19.4.1 COMPANY SNAPSHOT 261
19.4.2 REVENUE ANALYSIS 261
19.4.3 COMPANY SHARE ANALYSIS 262
19.4.4 PRODUCT PORTFOLIO 262
19.4.5 RECENT DEVELOPMENTS 263
19.5 BIO-RAD LABORATORIES, INC. 264
19.5.1 COMPANY SNAPSHOT 264
19.5.2 REVENUE ANALYSIS 264
19.5.3 COMPANY SHARE ANALYSIS 265
19.5.4 PRODUCT PORTFOLIO 265
19.5.5 RECENT DEVELOPMENT 265
19.6 AGILENT TECHNOLOGIES, INC. 266
19.6.1 COMPANY PROFILE 266
19.6.2 REVENUE ANALYSIS 266
19.6.3 PRODUCT PORTFOLIO 267
19.6.4 RECENT DEVELOPMENT 267
19.7 CENTOGENE N.V. 268
19.7.1 COMPANY SNAPSHOT 268
19.7.2 PRODUCT PORTFOLIO 268
19.7.3 RECENT DEVELOPMENT 268
19.8 F. HOFFMANN- LA ROCHE LTD 269
19.8.1 COMPANY SNAPSHOT 269
19.8.2 REVENUE ANALYSIS 269
19.8.3 PRODUCT PORTFOLIO 270
19.8.4 RECENT DEVELOPMENTS 270
19.9 GENERAL ELECTRIC COMPANY 271
19.9.1 COMPANY SNAPSHOT 271
19.9.2 REVENUE ANALYSIS 271
19.9.3 PRODUCT PORTFOLIO 272
19.9.4 RECENT DEVELOPMENTS 272
19.10 GENEDX, LLC 273
19.10.1 COMPANY SNAPSHOT 273
19.10.2 PRODUCT PORTFOLIO 273
19.10.3 RECENT DEVELOPMENT 273
19.11 GRAIL 274
19.11.1 COMPANY PROFILE 274
19.11.2 PRODUCT PORTFOLIO 274
19.11.3 RECENT DEVELOPMENT 274
19.12 HOLOGIC INC. 275
19.12.1 COMPANY SNAPSHOT 275
19.12.2 REVENUE ANALYSIS 275
19.12.3 PRODUCT PORTFOLIO 276
19.12.4 RECENT DEVELOPMENT 276
19.13 INVITAE CORPORATION 277
19.13.1 COMPANY PROFILE 277
19.13.2 REVENUE ANALYSIS 277
19.13.3 PRODUCT PORTFOLIO 278
19.13.4 RECENT DEVELOPMENT 278
19.14 NEUSOFT CORPORATION 279
19.14.1 COMPANY SNAPSHOT 279
19.14.2 REVENUE ANALYSIS 279
19.14.3 PRODUCT PORTFOLIO 280
19.14.4 RECENT DEVELOPMENT 280
19.15 NEOGENOMICS LABORATORIES 281
19.15.1 COMPANY SNAPSHOT 281
19.15.2 REVENUE ANALYSIS 281
19.15.3 PRODUCT PORTFOLIO 282
19.15.4 RECENT DEVELOPMENTS 282
19.16 PERKINELMER INC 283
19.16.1 COMPANY PROFILE 283
19.16.2 REVENUE ANALYSIS 283
19.16.3 PRODUCT PORTFOLIO 284
19.16.4 RECENT DEVELOPMENT 284
19.17 QIAGEN 285
19.17.1 COMPANY SNAPSHOT 285
19.17.2 REVENUE ANALYSIS 285
19.17.3 PRODUCT PORTFOLIO 286
19.17.4 RECENT DEVELOPMENT 286
19.18 SYSMEX CORPORATION 287
19.18.1 COMPANY SNAPSHOT 287
19.18.2 REVENUE ANALYSIS 287
19.18.3 PRODUCT PORTFOLIO 288
19.18.4 RECENT DEVELOPMENTS 288
20 QUESTIONNAIRE 289
21 RELATED REPORTS 293
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security